CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to EXEL

Cabozantinib

Phase 3
Exelixis, Inc. (EXEL)

Phase 3

Development Phase

10

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
EXELPhase 2

Cabozantinib Phase 2 Est. Readout

Cabozantinib
Q3 2027~Q
CT.gov
00%
Q3 '27
EXELPhase 2

Cabozantinib Phase 2 Est. Readout

Cabozantinib
Q3 2027~Q
CT.gov
00%
Jul '27
EXELPhase 2

Cabozantinib Phase 2 Est. Readout

Cabozantinib
Jul 2027~
CT.gov
00%
May '27
EXELPhase 2

Cabozantinib Phase 2 Est. Readout (Cyto-KIK)

Cabozantinib
May 2027~
CT.gov
00%
4mo
EXELPDUFA
Phase 3

FDA PDUFA Date cabozantinib

Cabozantinib
Mar 3
SEC
00%
Feb '27
EXELPhase 2

Cabozantinib Phase 2 Est. Readout

Cabozantinib
Feb 2027~
CT.gov
00%
Feb '27
EXELPhase 2

Cabozantinib Phase 2 Est. Readout

Cabozantinib
Feb 2027~
CT.gov
00%
Jan '27
EXELPhase 2

Cabozantinib Phase 2 Est. Readout

Cabozantinib
Jan 2027~
CT.gov
00%
Dec '26
EXELPhase 2

Cabozantinib Phase 2 Est. Readout

Cabozantinib
Dec 2026~
CT.gov
00%
Nov '26
EXELPhase 2

Cabozantinib Phase 2 Est. Readout (CANOPY)

Cabozantinib
Nov 2026~
CT.gov
00%
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.